Evidence map›Paper›PMID 36677116›Full record

ArticleMicromachines2022

Low-Cost Light-Based GelMA 3D Bioprinting via Retrofitting: Manufacturability Test and Cell Culture Assessment.

Juan Enrique Pérez-Cortez, Víctor Hugo Sánchez-Rodríguez, Salvador Gallegos-Martínez, Cristina Chuck-Hernández, Ciro A Rodriguez, Mario Moises Álvarez, Grissel Trujillo-de Santiago, Elisa Vázquez-Lepe, J Israel Martínez-López

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Juan Enrique Pérez-CortezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.ORCID 0000-0002-7877-9355
Víctor Hugo Sánchez-RodríguezTecnologico de Monterrey, Centro de Biotecnología-FEMSA, Monterrey 64849, NL, Mexico.
Salvador Gallegos-MartínezTecnologico de Monterrey, Centro de Biotecnología-FEMSA, Monterrey 64849, NL, Mexico.ORCID 0000-0001-5780-7946
Cristina Chuck-HernándezTecnologico de Monterrey, The Institute for Obesity Research, Monterrey 64849, NL, Mexico.ORCID 0000-0002-3555-4826
Ciro A RodriguezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.ORCID 0000-0003-2289-4239
Mario Moises ÁlvarezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.
Grissel Trujillo-de SantiagoTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.ORCID 0000-0001-9230-4607
Elisa Vázquez-LepeTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.ORCID 0000-0002-1228-9636
J Israel Martínez-LópezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey 64849, NL, Mexico.ORCID 0000-0001-7475-8138
Tecnológico de Monterrey · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-based bioprinter manufacturing technology is still prohibitively expensive for organizations that rely on accessing three-dimensional biological constructs for research and tissue engineering endeavors. Currently, most of the bioprinting systems are based on commercial-grade-based systems or modified DIY (do it yourself) extrusion apparatuses. However, to date, few examples of the adoption of low-cost equipment have been found for light-based bioprinters. The requirement of large volumes of bioinks, their associated cost, and the lack of information regarding the parameter selection have undermined the adoption of this technology. This paper showcases the retrofitting and assessing of a low-cost Light-Based 3D printing system for tissue engineering. To evaluate the potential of a proposed design, a manufacturability test for different features, machine parameters, and Gelatin Methacryloyl (GelMA) concentrations for 7.5% and 10% was performed. Furthermore, a case study of a previously seeded hydrogel with C2C12 cells was successfully implemented as a proof of concept. On the manufacturability test, deviational errors were found between 0.7% to 13.3% for layer exposure times of 15 and 20 s. Live/Dead and Actin-Dapi fluorescence assays after 5 days of culture showed promising results in the cell viability, elongation, and alignment of 3D bioprinted structures. The retrofitting of low-cost equipment has the potential to enable researchers to create high-resolution structures and three-dimensional in vitro models.

Indexed as

bioinksbioprintingcell cultureDIYDLPGelMALCDlow costSLAstereolithographyUV

Identifiers

PMID36677116
PMCPMC9863692
OpenAlexW4312202074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.